NCT06554054View on ClinicalTrials.gov

A Study of GZR18 Tablet in Chinese Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 9, 2024

Study Completion Date

December 9, 2024

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GZR18

Oral administered the GZR18 tablet

Trial Locations (1)

Unknown

Study Site 01, Beijing

Sponsors
All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY

NCT06554054 - A Study of GZR18 Tablet in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter